Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

BACKGROUNDS: It has been extensively proved that the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) is superior to that of cytotoxic chemotherapy in advanced non-small cell lung cancer (NSCLC) patients harboring sensitive EGFR mutations. However, the question of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaxiong, Sheng, Jin, Kang, Shiyang, Fang, Wenfeng, Yan, Yue, Hu, Zhihuang, Hong, Shaodong, Wu, Xuan, Qin, Tao, Liang, Wenhua, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164616/
https://www.ncbi.nlm.nih.gov/pubmed/25222496
http://dx.doi.org/10.1371/journal.pone.0107161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164616/
https://www.ncbi.nlm.nih.gov/pubmed/25222496
http://dx.doi.org/10.1371/journal.pone.0107161

Ejemplares similares